Insider · CIK 0001405625
Glynn Wilson
Files at CVKD (Cadrenal Therapeutics, Inc.), CABR (Caring Brands, Inc.). First filing -, latest -.
In brief
Glynn Wilson files SEC Form 4 as director, CEO and 10% owner at CVKD (Cadrenal Therapeutics, Inc.), and also at CABR (Caring Brands, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Glynn Wilson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | CABR Caring Brands, Inc. | DDisposition to issuer Common Stock | -1,500,000 | $0.50 | $750k | 672,592 | Mar 27, 2026 |
| Dec 11, 2025 | CABR Caring Brands, Inc. | AGrant or award Common Stock | -126,720 | $0.00 | $0 | 2,126,720 | Dec 15, 2025 |
| Dec 11, 2025 | CABR Caring Brands, Inc. | AGrant or award Common Stock | -45,872 | $0.00 | $0 | 2,172,592 | Dec 15, 2025 |
| Jan 23, 2025 | CVKD Cadrenal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +20,000 | $0.00 | $0 | 20,000 | Jan 24, 2025 |
Questions about Glynn Wilson
Answered from the filings on this page, as of the latest one.
Is Glynn Wilson buying or selling?
Glynn Wilson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Glynn Wilson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Glynn Wilson has 0.
Where does Glynn Wilson file Form 4?
Glynn Wilson has filed Form 4 at CVKD (Cadrenal Therapeutics, Inc.); CABR (Caring Brands, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.